MedPath

A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders

Not Applicable
Recruiting
Conditions
Cognitive Disorder
Registration Number
NCT06801171
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

The study aims to test a program combining cognitive behavioral therapy techniques, positive psychology techniques, mindfulness meditation and yoga, in order to improve resilience in patient with minor cognitive disorder.

This intervention will be compared to a control group, but also with a group testing another intervention (an intervention that does not improve resilience in the elderly, namely a "cognitive stimulation" intervention) in order to ensure that the effect potentially obtained is not due to the simple management of the participant.

The duration of the intervention will be 3 months, with an evaluation directly before and after the intervention.

In addition, in order to best evaluate the effectiveness of the interventions over time, two follow-up measurements will be proposed: a measurement one month after the intervention, then a final one three months after the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  1. Man or Woman aged > 60 years
  2. Have a minor neurocognitive disorder according to the criteria of the DSM 5
  3. Score of 145 or less on the Wagnild and Young Resilience Scale (RS) (Wagnild, 2009).
  4. Subject able to read and write French;
  5. Subject beneficiaries of a social security scheme;
  6. Ability to understand and sign free and informed consent.
Exclusion Criteria
  1. Subject already practicing meditation and/or yoga and/or Tai Chi
  2. Subject currently undergoing psychological therapy (whatever the approach)
  3. Subject with a major hearing, visual or motor disability likely to interfere with the proposed interventions or the performance of assessments;
  4. Presence and/or recent history (within the last 5 years prior to inclusion in the study) of major psychiatric disorders (e.g., schizophrenia, severe depression, addiction, bipolar disorders, psychotic disorders, risk of dissociation, panic attack, generalized anxiety disorder, etc.)
  5. If taking psychotropic treatment, the dose must have been stable for 4 weeks
  6. Vulnerable persons are defined in Articles L1121-5 to -8

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Improvement of resilience of patients suffering from mild neurocognitive disorder (NCD) compared to a passive control group (without any intervention).Pre intervention

Comparison of scores at Brief-COPE between group control and mixed intervention mixed The Brief-COPE is a self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event. Coping" is defined broadly as an effort used to minimise distress associated with negative life experiences.

The questionnaire contains 28 questions. Each question is measured using a 4-point Likert scale from 1 I haven't been doing this at all to 4= I've been doing this a lot Higher scores indicate a better coping.

Secondary Outcome Measures
NameTimeMethod
Persistence of improvement in resilience over timeThrough study completion, an average of 3 months

Comparison of scores at Brief-COPE at different time points The Brief-COPE is a self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event. Coping" is defined broadly as an effort used to minimise distress associated with negative life experiences.

The questionnaire contains 28 questions. Each question is measured using a 4-point Likert scale from 1 I haven't been doing this at all to 4= I've been doing this a lot

Higher scores indicate a better coping.

Trial Locations

Locations (1)

CHU de Nice

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath